echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Cell: Mitochondria initiate a new type of cell death, from pyrotic to necrosis

    Cell: Mitochondria initiate a new type of cell death, from pyrotic to necrosis

    • Last Update: 2022-11-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    As researchers gain a deeper understanding of the dynamic world inside the human immune system, it is becoming increasingly clear that mitochondria are key regulators of our body's
    response to disease.

    In addition to their traditional work as the "powerhouse of the cell," mitochondria play a key role in the life of the cell – and more importantly, in the death of the cell to guide inflammation and antimicrobial
    This means that mutations in mitochondria-related genes may affect the immune system's ability to fight disease and even trigger an overreaction that leads to inflammatory diseases
    such as cancer or Crohn's disease.
    Although it is increasingly understood how mitochondria regulate the immune system, how they regulate is still relatively unknown
    Figuring out how mitochondrial mutations interfere with the immune response could be key to understanding disease mechanisms such as tuberculosis, leprosy and Parkinson's disease, and potentially opening the door
    to new treatments.

    A team of researchers led by Robert O.
    Watson and Kristin L.
    Patrick of Texas A&M University School of Medicine recently published a study in the journal Cell that solved some of the mystery
    Watson and Patrick studied mutations
    in the LRRK2 protein in macrophages or leukocytes from animal models.
    When mutated macrophages are exposed to bacteria that cause tuberculosis, mitochondria initiate a new type of cell death, from pyrotic to necrosis

    When cells die of necrosis, they release chemical signals that cause an aggressive inflammatory immune response
    For animal models with LRRK2 mutations, switching to necrotic cell death made them more susceptible to tuberculosis infection and triggered excessive inflammation of infected tissue, leading to worse outcomes

    Although this research has focused on macrophage and tuberculosis infection, the newly discovered disease mechanisms may have broader implications

    "Mutations in the LRRK2 protein have been linked to a variety of important human diseases that, ostensibly, have little link between them — Parkinson's, leprosy, inflammatory bowel disease and Crohn's disease, and cancer
    ," Patrick said.
    "Our work shows that a common mutation in LRRK2 triggers a new type of cell death, triggering a high inflammatory response
    to infection.
    Cell death and inflammation may be what
    links LRRK2 to all these different human diseases.

    The team's findings have potential real-world applications to provide much-needed relief to patients, and Patrick and Watson are poised to move on to the next phase of research, using LRRK2 inhibitors already developed by pharmaceutical companies to test their theory

    "Our study is geared towards taking these drugs and studying them
    in the context of the immune response.
    We are about to begin research to see if drugging LRRK2 and other proteins involved in this new cell death pathway can improve outcomes for
    TB infection.

    The team's findings underscore the critical role
    of basic science in developing new treatment options for patients with life-changing diseases.
    In Patrick's words, "It's exciting
    to see basic science research digging deeper into how molecules work to identify unexpected connections between seemingly unrelated diseases and open up new avenues for therapeutic intervention.
    " ”

    Article Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.